Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 3/2006

01-07-2006 | Original Article

Evaluation of matrix metalloproteinase-2 (mmp-2) activity with film in situ zymography for improved cytological diagnosis of Breast tumors

Authors: Akira Fujiwara, Eri Shibata, Hitomi Terashima, Akemi Shishido, Junko Nishiki, Kyotaro Yoshida, Keisuke Miyauchi, Ayako Madachi, Nariaki Matsuura

Published in: Breast Cancer | Issue 3/2006

Login to get access
Metadata
Title
Evaluation of matrix metalloproteinase-2 (mmp-2) activity with film in situ zymography for improved cytological diagnosis of Breast tumors
Authors
Akira Fujiwara
Eri Shibata
Hitomi Terashima
Akemi Shishido
Junko Nishiki
Kyotaro Yoshida
Keisuke Miyauchi
Ayako Madachi
Nariaki Matsuura
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 3/2006
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.2325/jbcs.13.272

Other articles of this Issue 3/2006

Breast Cancer 3/2006 Go to the issue

Review Article

Immunohistochemical evaluation for hormone receptors in Breast Cancer: A practically useful evaluation system and handling protocol

Case Report

Primary Breast mucosa-associated lymphoid tissue (malt) lymphoma with high-grade transformation evidenced by prominent lymphoepithelial lesions

Review Article

Problems in histological grading of malignancy and its clinical significance in patients with operable Breast Cancer

Original Article

RETRACTED ARTICLE: Age-period-cohort analysis of female Breast Cancer mortality in Korea

Original Article

Tolerability and safety of classic cyclophosphamide, methotrexate, and fluorouracil treatment in japanese patients with early Breast Cancer

Review Article

Significance and problems in evaluations of pathological responses to neoadjuvant therapy for Breast Cancer

2024 ASCO Annual Meeting Coverage

Highlights of the Day: Breast cancer – metastatic

Breast Cancer Video

In this session, Dr. Wolff provides his key takeaways from the data presented in the metastatic breast cancer oral abstract session at ASCO 2024.

Watch now

Highlights of the Day: Gynecologic cancer

Gynecologic Cancer Video

Highlights of the Day: Breast Cancer – local/regional/adjuvant

Breast Cancer Video

Neoadjuvant dual immunotherapy improves melanoma outcomes

04-06-2024 Melanoma News

» View more highlights on the ASCO 2024 congress hub page

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits